NasdaqCM:CORTPharmaceuticals
Is Corcept Therapeutics (CORT) Pricing Reflect Long Term Value After Recent Share Rebound
If you are wondering whether Corcept Therapeutics at around US$46.57 offers good value today, it helps to step back and look at how the current price lines up with different valuation yardsticks.
The stock has moved sharply in the short term, with a 6.1% return over the last week, 38.5% over the past month, and 21.9% year to date, while the 1 year return stands at a 32.8% decline and the 3 and 5 year returns are 109.5% and 96.0% respectively.
These swings have kept Corcept on many investors'...